mk 912 has been researched along with medetomidine in 1 studies
Studies (mk 912) | Trials (mk 912) | Recent Studies (post-2010) (mk 912) | Studies (medetomidine) | Trials (medetomidine) | Recent Studies (post-2010) (medetomidine) |
---|---|---|---|---|---|
60 | 3 | 2 | 1,335 | 296 | 444 |
Protein | Taxonomy | mk 912 (IC50) | medetomidine (IC50) |
---|---|---|---|
Alpha-2A adrenergic receptor | Homo sapiens (human) | 3.4 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Clark, TP; Schwartz, DD | 1 |
1 other study(ies) available for mk 912 and medetomidine
Article | Year |
---|---|
Affinity of detomidine, medetomidine and xylazine for alpha-2 adrenergic receptor subtypes.
Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-Antagonists; Animals; Binding, Competitive; Cell Line; HT29 Cells; Humans; Hypnotics and Sedatives; Imidazoles; Medetomidine; PC12 Cells; Quinolizines; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Structure-Activity Relationship; Xylazine | 1998 |